Form 10-Q AMGEN INC For: Mar 31

Go back to Form 10-Q AMGEN INC For: Mar 31

Amgen (AMGN) PT Lowered to $183 at RBC Capital

April 25, 2018 7:41 AM EDT

RBC Capital lowered its price target on Amgen (NASDAQ: AMGN) to $183.00 (from $189.00) while maintaining a Sector Perform rating.

Analyst Kennen MacKay said AMGN's surprise Q1:18 top and bottom line beats are tempered by legacy base business products largely driving the revenue beat.

... More